Pirfenidone product-specific bioequivalence guidance

Pirfenidone film-coated tablets 267, 537 and 801 mg, and hard capsules 267 mg product-specific bioequivalence guidance (PDF/140.33 KB) (new)

Draft: consultation open

First published: 22/06/2023
Consultation dates: 22/06/2023 to 30/09/2023
EMA/CHMP/901584/2022

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

You just read:

Pirfenidone product-specific bioequivalence guidance

Distribution channels: Healthcare & Pharmaceuticals Industry

EIN Presswire's priority is author transparency. We do our best to weed out false and misleading content. The content above is the sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above.